HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Abdel-Rahman, A. M. O. Articles by Bakr, S. I. Search for Related Content PubMed PubMed Citation Articles by Abdel-Rahman, A. M. O. Articles by Bakr, S. I.

A Comparative Study of Two Angiogenic Factors^*

Vascular Endothelial Growth Factor and Angiogenin in Induced Sputum From Asthmatic Children in Acute Attack

^* From the Department of Pediatrics (Drs. Abdel-Rahman and El-Sahrigy), National Research Center; and Department of Clinical Pathology (Dr. Bakr), Ain Shams University Hospital, Cairo, Egypt.

Correspondence to: Azza M. O. Abdel-Rahman, MD, 5, Said Bahgat St, Heliopolis, Cairo, Egypt; e-mail: azzaomar74{at}yahoo.com

Abstract

Background: Angiogenesis is a prerequisite for airway remodeling in bronchial asthma. Several factors may play important roles in inflammation and angiogenesis through effects on inflammatory cell infiltration or neovascularization.

Objectives: (1) To determine the levels of vascular endothelial growth factor (VEGF) and angiogenin in sputum supernatants of asthmatic children during the acute attack and 6 weeks after start of therapy; and (2) to correlate their levels with the degree of asthma severity.

Subjects and methods: Twenty asthmatic children with acute attack (mean age, 9.6 ± 3.5 years [± SD]) and 12 sex- and age-matched healthy control children were enrolled in the study. Sputum supernatants were collected for determination of VEGF and angiogenin levels. Serum samples were withdrawn for IgE measurement. The above tests were performed using an enzyme-linked immunosorbent assay. The FEV₁ was measured using spirometry. VEGF, angiogenin, and FEV₁ estimations were repeated for asthmatic children 6 weeks after start of therapy.

Results: During the acute attack, asthmatic children had significantly higher levels of VEGF and angiogenin than in healthy control children (p < 0.001). VEGF and angiogenin levels showed more elevation with increase in asthma severity (p < 0.001). A significant positive correlation existed between both angiogenic factors (r = 0.98, p < 0.001). A negative significant correlation was found between FEV₁ percentage of predicted and both VEGF (r = – 0.99, p < 0.001) and angiogenin (r = – 0.97, p < 0.001). A nonsignificant correlation was found between serum IgE and sputum VEGF (r = 0.09, p > 0.05). Although there was a significant decrease in the levels of both VEGF and angiogenin after 6 weeks of treatment with corticosteroid inhalation therapy, the levels did not reach normal control levels (p < 0.001 and p < 0.05, respectively).

Conclusions: Our results show that both VEGF and angiogenin levels were elevated in children with acute asthma. The study also suggests that increased severity of bronchial asthma in children is associated with the expression of both angiogenic factors, which are implicated in asthma pathogenesis. After 6 weeks of therapy, the levels of both angiogenic factors showed significant decrease.

Key Words: angiogenesis • angiogenin • asthma • inhaled corticosteroid • vascular endothelial growth factor